Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells
Ex vivo gene therapy (GT) is a promising treatment for inherited genetic diseases. An ideal transduction protocol should determine high gene marking in long-term self-renewing hematopoietic stem cells (HSCs), preserving their repopulation potential during in vitro manipulation. In the context of the...
Main Authors: | Valentina Poletti, Annita Montepeloso, Danilo Pellin, Alessandra Biffi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050123001705 |
Similar Items
-
Identification of a small molecule for enhancing lentiviral transduction of T cells
by: Paulina Malach, et al.
Published: (2023-12-01) -
Prostaglandin E2 regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors
by: Regina E. Maldve, et al.
Published: (2000-06-01) -
Regulated expression of CXCR4 constitutive active mutants revealed the up-modulated chemotaxis and up-regulation of genes crucial for CXCR4 mediated homing and engraftment of hematopoietic stem/progenitor cells
by: Sharma M, et al.
Published: (2013-04-01) -
Murine Dendritic Cells for Immunotherapy and Vaccine Development: Generation, Optimization and Transduction
by: Mona Sadat Larijani, et al.
Published: (2020-12-01) -
FDA-Approved Drug Screening for Compounds That Facilitate Hematopoietic Stem and Progenitor Cells (HSPCs) Expansion in Zebrafish
by: Zhi Feng, et al.
Published: (2021-08-01)